Cargando…
A new era in hypertension research: discussing the findings of ALLHAT
The key question in hypertension research today is, "Does it matter how elevated blood pressure is lowered?" The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) initiated in 1994 serves as a model for comparative trials. Its strengths include its indepe...
Autor principal: | Furberg, Curt D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64822/ https://www.ncbi.nlm.nih.gov/pubmed/11806805 http://dx.doi.org/10.1186/cvm-2-6-249 |
Ejemplares similares
-
Impact of the ALLHAT Study Results on Managed Care
por: Anderson, Robert J.
Publicado: (2003) -
Comments on ALLHAT and doxazosin
por: Krakoff, Lawrence R
Publicado: (2001) -
Antihypertensive Drug Effects on Renal Function and Myocardial Infarction and Implications of the ALLHAT Study Results
por: Curtiss, Frederic R.
Publicado: (2003) -
Current Controlled Trials in Cardiovascular Medicine: a new journal for a new age (http://cvm.controlled-trials.com)
por: Furberg , Curt, et al.
Publicado: (2000) -
Prevention of Heart Failure in Hypertension—Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study
por: Johnson, Kyle, et al.
Publicado: (2019)